Jim Simons
SGNT

Jim Simons’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Jim Simons’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-90,700
Closed -$2.21M – 3533
2015
Q2 		$2.21M Buy
+90,700
New +$2.17M 0.01% 2001
2015
Q1 		– Sell
-17,000
Closed -$427K – 3469
2014
Q4 		$427K Buy
+17,000
New +$499K ﹤0.01% 2481
2014
Q1 		– Sell
-98,500
Closed -$2.5M – 3154
2013
Q4 		$2.5M Buy
98,500
+41,900
+74% +$946K 0.01% 1628
2013
Q3 		$1.16M Buy
56,600
+46,400
+455% +$1.03M ﹤0.01% 1942
2013
Q2 		$214K Buy
+10,200
New +$182K ﹤0.01% 2505

Other funds holding SGNT

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Jim Simons's SGNT Position: Q3 2015 in Review

Jim Simons sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2015, closing a stake of 90,700 shares — an estimated $2.21M sold.

Jim Simons first reported a position in SGNT in Q2 2013 and held it in 5 quarters. The position peaked at $2.5M in Q4 2013. 127 funds tracked by Wall St. Rank hold SGNT as of Q3 2015.

  • Jim Simons reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2015 after selling out during the quarter.
  • Jim Simons sold 90,700 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2015, an estimated $2.21M.
  • Jim Simons first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 5 quarters.
  • Jim Simons's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $2.5M in Q4 2013.
  • 127 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2015.

Based on Renaissance Technologies's 13F filing for Q3 2015, filed 12 Nov 2015.